Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Abstract

loading...

About

This paper, published in 1950, received 444 indexed citations. Written by Katrin Sangkuhl, JJ Swen, Müller Dj, Kazutaka Shimoda, E D Kharasch, Andrea Gaedigk, Henry M. Dunnenberger, Teri E. Klein and Julia Stingl covering the research area of Oncology, Pharmacology and Pharmacology. It is primarily cited by scholars working on Pharmacology (326 citations), Pediatrics, Perinatology and Child Health (138 citations) and Pharmacology (116 citations). Published in Clinical Pharmacology & Therapeutics.

In The Last Decade

doi.org/10.1002/cpt.597 →

Countries where authors are citing Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Since Specialization
Citations

This map shows the geographic impact of Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update more than expected).

Fields of papers citing Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1002/cpt.597.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026